aTyr Pharma | LIFE - Ordinary Share Capital


aTyr Pharma reported $62.99M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Ardelyx USD 246.97M 2.62M Mar/2026
aTyr Pharma USD 62.99M 46.35M Mar/2026
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Cipla INR 807.78M 17K Mar/2026
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 94.55M 1000 Mar/2026
CSL USD 482.13M 93.87M Dec/2025
Curis USD 2M 10.93M Mar/2026
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
Grifols EUR 680.58M 846.11K Dec/2025
Lakefront Biotherapeutics EUR 65.9M 0 Mar/2026
Novartis USD 1.9B 7.38M Jun/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
United Therapeutics USD 42.16M 1.49M Mar/2026